期刊文献+

EPO-R在结肠癌组织中的表达及MVD测定的意义

下载PDF
导出
摘要 为探讨促红细胞生成素(EPO-R)的表达及微血管密度(MVD)与结肠癌组织中血管生成、侵袭和转移的关系。笔者应用免疫组化方法检测32例结肠癌组织及13例正常结肠组织中EPO-R的表达,并对血管进行CD34相关抗原的免疫组化染色,计数MVD。结果示,EPO-R表达及MVD值与肿瘤分化、Dukes分期、淋巴结转移有关(P<0.05)。EPO-R表达阳性组织中,MVD计数显著高于EPO-R表达阴性者(P<0.05)。提示EPO-R表达及MVD值与结肠癌侵袭转移有密切关系,可能成为结肠癌治疗的标靶和预后指标。
出处 《中国普通外科杂志》 CAS CSCD 2007年第4期381-383,共3页 China Journal of General Surgery
  • 相关文献

参考文献2

二级参考文献20

  • 1Ellis LM.Angiogenesis and its role in colorectal tumor and metastasis formation[J].Semin Oncol,2004,31(6):3-9.
  • 2Gupta K,Zhang J.Angiogenesis:a curse or cure?[J].Postgrad Med J,2005,81(954):236-242.
  • 3Paku S,Kopper L,Nagy P.Development of the vasculature in "pushing-type" liver metastases of an experimental colorectal cancer[J].Int J Cancer,2005,115(6):893-902.
  • 4Paku S,Kopper L,Nagy P.Development of the vasculature in "pushing-type" liver metastases of an experimental colorectal cancer[J].Int J Cancer,2005,11:893-902.
  • 5Velde EA,Reijerkerk A,Brandsma D,et al.Early endostatin treatment inhibits metastatic seeding of murine colorectal cancer cells in the liver and their adhesion to endothelial cells[J].Br J Cancer,2005,92(4):729-735.
  • 6Hanrahan V,Currie MJ,Gunningha m,et al.the angiogenic switch for vascular endothelial growth factor (VEGF)-A,VEGF-B,VEGF-C,and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression[J].J Pathol,2003,200(2):183-194.
  • 7Rehman,Jayson,Molecular imaging of antiangiogenic agents[J].Oncologist,2005,10(2):92-103.
  • 8Aggarwal S,Chu E.Current therapies for advanced colorectal cancer[J].Oncology-(Williston-Park),2005,19(5):589-595.
  • 9Wiedmann MW,Caca K.Molecularly targeted therapy for gastrointestinal cancer[J].Curr Cancer Drug Targets,2005,5(3):171-193.
  • 10DePrimo SE,Wong LM,Khatry DB,et al.Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial:a novel strategy for biomarker identification[J].BMC Cancer,2003,3(1):3.

共引文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部